Japan's Nikkei share average rose to a fresh 15-year high on Monday, tracking gains in U.S. shares, while Eisai Co jumped over 20 percent after a brokerage upgraded the stock, citing the effectiveness of its drug to treat Alzheimer's disease.
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon